Company intelligence / Profile preview

Three

Paris, France

Ownership: Private
Development stage: Other

Overview

3Biotech is a Paris-based independent consultancy specializing in Chemistry, Manufacturing, and Controls (CMC) strategy for early-stage biotech companies, helping them accelerate drug development from research to first-in-human clinical trials. The firm does not develop its own drugs but partners with innovators to overcome regulatory, cost, and resource challenges, focusing on tailored, risk-based CMC approaches for each client’s unique needs.

Modalities: Small moleculeBiologic
Industry: Consulting

Partnerships

Global CROs and CDMOs

Beyond the preview

Go deeper on Three.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Three.

Explore the full profile